Amrutanjan Health Care Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amrutanjan Health Care Limited with three other companies in this sector in India: RPG Life Sciences Limited (2017 sales of 3.04 billion Indian Rupees [US$47.49 million] ), Kopran Limited (3.10 billion Indian Rupees [US$48.32 million] of which 100% was Pharmaceuticals), and Albert David Limited (3.05 billion Indian Rupees [US$47.52 million] ).

Sales Analysis. During the year ended March of 2017, sales at Amrutanjan Health Care Limited were 2.24 billion Indian Rupees (US$34.94 million). This is an increase of 26.8% versus 2016, when the company's sales were 1.77 billion Indian Rupees. This was the fourth straight year of sales growth at Amrutanjan Health Care Limited.